Cancer Care Clinic and Hospital, Nagpur, India Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2009
NCT00843050
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

Medical Oncologist, Cancer Care Clinic and Hospital, Nagpur, India

Active Ingredients

Drugs in Phase 2 Trials (1)

riviciclib (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Lymphoma (Phase 2)

Lymphoma, Mantle-Cell (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1